CIK 0001005286
- Accelerated filer
- Smaller reporting company
LIFECORE BIOMEDICAL, INC. \DE\
Sign in to watch- Ticker
- LFCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- May 25
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943025618
- Phone
- +1 952-368-4300
- Business address
- 3515 LYMAN BOULEVARD, CHASKA, MN, 55318
- Former names
- LANDEC CORP \CA\
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-19 | Bolles Albert D. Chief Executive Officer | Purchase | +10,000 | $10.98 | $110K | 36,152 |
| 2021-01-18 | Morberg John D Chief Financial Officer | Grant or award · Restricted Stock Unit | +17,500 | 17,500 | ||
| 2021-01-18 | Morberg John D Chief Financial Officer | Grant or award · Incentive Stock Option (Right to Buy) | +21,258 | $10.83 | $230K | 21,258 |
| 2021-01-18 | Morberg John D Chief Financial Officer | Grant or award · Non-Qualified Stock Option (Right to Buy) | +78,742 | $10.83 | $853K | 78,742 |
| 2021-01-12 | OBUS NELSON Director | Purchase | +13,600 | $10.74 | $146K | 2,905,300 |
| 2021-01-11 | OBUS NELSON Director | Purchase | +6,400 | $10.81 | $69K | 2,891,700 |
| 2020-10-19 | McLaughlin Brian F Chief Financial Officer | Option exercise | +5,000 | $10.09 | $50K | 19,532 |
| 2020-10-19 | McLaughlin Brian F Chief Financial Officer | Shares withheld for taxes | −2,479 | $10.09 | $25K | 17,053 |
| 2020-10-19 | McLaughlin Brian F Chief Financial Officer | Option exercise · Restricted Stock Unit | −5,000 | 0 | ||
| 2020-10-15 | PANKOPF TONIA L Director | Grant or award | +2,200 | $10.36 | $23K | 44,237 |
| 2020-10-15 | PANKOPF TONIA L Director | Option exercise · Restricted Stock Unit | −2,200 | 0 | ||
| 2020-10-15 | HOUDE LOVAS KATRINA Director | Grant or award | +7,334 | $10.36 | $76K | 7,334 |
| 2020-10-15 | HOUDE LOVAS KATRINA Director | Option exercise · Restricted Stock Unit | −7,334 | 0 | ||
| 2020-10-15 | OBUS NELSON Director | Grant or award | +2,200 | $10.36 | $23K | 36,115 |
| 2020-10-15 | OBUS NELSON Director | Option exercise · Restricted Stock Unit | −2,200 | 0 | ||
| 2020-10-15 | Carosella Deborah D Director | Grant or award | +2,200 | $10.36 | $23K | 21,226 |
| 2020-10-15 | Carosella Deborah D Director | Option exercise · Restricted Stock Unit | −2,200 | 0 | ||
| 2020-10-15 | MACALUSO CHARLES Director | Grant or award | +5,501 | $10.36 | $57K | 5,501 |
| 2020-10-15 | MACALUSO CHARLES Director | Option exercise · Restricted Stock Unit | −5,501 | 0 | ||
| 2020-10-15 | Powell Andrew Kenneth William Director | Grant or award | +2,200 | $10.36 | $23K | 12,115 |
Page 14 of 17 · 334 trades